{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T10:23:33Z","timestamp":1787394213524,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.farma.2026.03.016","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:27:43Z","timestamp":1787390863000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8635-6084","authenticated-orcid":false,"given":"Andrea","family":"Rodr\u00edguez Esqu\u00edroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0126-7431","authenticated-orcid":false,"given":"Javier","family":"Garj\u00f3n Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9225-5323","authenticated-orcid":false,"given":"Amaya","family":"Echeverr\u00eda Gorriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0571-5438","authenticated-orcid":false,"given":"Lorea","family":"Sanz \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-6467","authenticated-orcid":false,"given":"Marta","family":"Mar\u00edn Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-930X","authenticated-orcid":false,"given":"In\u00e9s","family":"Aguinaga Ontoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.farma.2026.03.016_bb0005","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.3390\/jcm12227030","article-title":"Pharmaceutical interventions for inpatients with liver cirrhosis and liver transplantation: a systematic review of experimental studies","volume":"12","author":"Jibai","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.farma.2026.03.016_bb0010","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/hep.31548","article-title":"Appropriate and potentially inappropriate medication use in decompensated cirrhosis","volume":"73","author":"Thomson","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.farma.2026.03.016_bb0015","first-page":"32","article-title":"Polypharmacy: evaluating risks and deprescribing","volume":"100","author":"Halli-Tierney","year":"2019","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.farma.2026.03.016_bb0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/bcp.14177","article-title":"Medication safety in patients with hepatic impairment: a survey of community pharmacists' knowledge level and their practice in caring for these patients","volume":"86","author":"Weersink","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.farma.2026.03.016_bb0025","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/hep4.1612","article-title":"Improving medication-related outcomes in chronic liver disease","volume":"4","author":"Hayward","year":"2020","journal-title":"Hepatol Commun"},{"issue":"12","key":"10.1016\/j.farma.2026.03.016_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121207","article-title":"Medication discrepancies and regimen complexity in decompensated cirrhosis: implications for medication safety","volume":"14","author":"Hayward","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"suppl 2","key":"10.1016\/j.farma.2026.03.016_bb0035","first-page":"95","article-title":"High-risk medication-related problems are prevalent in people with decompensated cirrhosis","volume":"32","author":"Hayward","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"suppl 2","key":"10.1016\/j.farma.2026.03.016_bb0040","first-page":"87","article-title":"Polypharmacy is associated with high-risk medication-related problems in people with decompensated cirrhosis","volume":"32","author":"Kelly","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.farma.2026.03.016_bb0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13063-017-2075-4","article-title":"Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial","volume":"18","author":"Hayward","year":"2017","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.farma.2026.03.016_bb0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/hep4.1334","article-title":"Medication-related problems in outpatients with decompensated cirrhosis: opportunities for harm prevention","volume":"3","author":"Hayward","year":"2019","journal-title":"Hepatol Commun"},{"issue":"9","key":"10.1016\/j.farma.2026.03.016_bb0055","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/imj.14986","article-title":"Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis","volume":"50","author":"Hayward","year":"2020","journal-title":"Intern Med J"},{"issue":"8","key":"10.1016\/j.farma.2026.03.016_bb0060","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00228-013-1502-z","article-title":"Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations","volume":"69","author":"Franz","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.farma.2026.03.016_bb0065","article-title":"Interventions to improve the appropriate use of polypharmacy for older people","volume":"10","author":"Cole","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.farma.2026.03.016_bb0070","article-title":"Medication review in hospitalised patients to reduce morbidity and mortality","volume":"1","author":"B\u00fclow","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.farma.2026.03.016_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102317","article-title":"Systematic review and meta-analysis on the effectiveness of multidisciplinary interventions to address polypharmacy in community-dwelling older adults","volume":"98","author":"Roncal-Belzunce","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"10","key":"10.1016\/j.farma.2026.03.016_bb0080","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1111\/jgs.19035","article-title":"Clinical impact of medication review and deprescribing in older inpatients: a systematic review and meta-analysis","volume":"72","author":"Carollo","year":"2024","journal-title":"J Am Geriatr Soc"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326001637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326001637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:27:45Z","timestamp":1787390865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634326001637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":16,"alternative-id":["S1130634326001637"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2026.03.016","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.03.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}